Dr Reddy’s Labs Q3 Results: Profit grows 2% YoY to ₹1413 crore; revenue up 16% – Mint

1. Dr Reddy’s Labs Q3 Results: Profit grows 2% YoY to ₹1413 crore; revenue up 16%  Mint
2. Dr Reddy’s Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth  Moneycontrol
3. Q3FY25: Dr. Reddy’s to focus on continued CapEx investment, R&D and increasing capacity of existing portfolio  The Financial Express
4. Dr Reddy’s Q3 results: Check earnings preview and options strategy ahead of results  Upstox
5. Dr Reddy’s Laboratories consolidated net profit rises 2.38% in the December 2024 quarter  Business Standard

 Dr Reddy’s Labs Q3 Results: Profit grows 2% YoY to ₹1413 crore; revenue up 16%  MintDr Reddy’s Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth  MoneycontrolQ3FY25: Dr. Reddy’s to focus on continued CapEx investment, R&D and increasing capacity of existing portfolio  The Financial ExpressDr Reddy’s Q3 results: Check earnings preview and options strategy ahead of results  UpstoxDr Reddy’s Laboratories consolidated net profit rises 2.38% in the December 2024 quarter  Business Standard  Top stories – Google News